— Know what they know.
Not Investment Advice

ARDX NASDAQ

Ardelyx, Inc.
1W: -1.7% 1M: +5.5% 3M: +10.8% YTD: +3.2% 1Y: +51.9% 3Y: +42.4% 5Y: +273.5%
$6.11
-0.24 (-3.78%)
 
Weekly Expected Move ±7.7%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 53 · $1.5B mcap · 236M float · 1.60% daily turnover · Short 48% of daily vol

Cash Flow Trends

Operating Cash Flow
-$42M +5.2% ▲
Capital Expenditures
$1M -47.6% ▼
5Y CAGR: +35.7%
Free Cash Flow
-$44M +4.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$3M -92.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$158M-$67M-$66M-$39M-$62M
Depreciation & Amort.$1M$1M$1M$2M$3M
Stock-Based Comp.$12M$11M$14M$37M$49M
Change in Working Capital-$12M-$20M-$43M-$49M-$31M
Other Non-Cash Items$4M$5M$5M$4M-$2M
Operating Cash Flow-$153M-$70M-$90M-$45M-$42M
— Investing Activities —
Capital Expenditures-$2M-$55K-$344K-$1M-$1M
Acquisitions (Net)-$53M$0$0$0$0
Investment Purchases-$73M-$50M-$215M-$195M-$219M
Investment Sales$126M$67M$84M$178M$211M
Other Investing$53M$2M$0$0$0
Investing Cash Flow$51M$18M-$131M-$18M-$9M
— Financing Activities —
Net Debt Issuance-$19M-$6M$22M$99M$49M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$1M$10M$5M-$1M$0
Financing Cash Flow$83M$75M$146M$107M$55M
Net Change in Cash-$19M$24M-$75M$43M$3M
Cash End of Period$72M$96M$21M$65M$68M
Free Cash Flow-$154M-$70M-$90M-$46M-$44M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms